Inka Health applies advanced AI-driven analytics to real‑world multimodal oncology data, enabling faster, more precise clinical research and drug development. By combining imaging, genomics, and patient outcomes, the platform generates actionable insights that help researchers identify promising therapies and accelerate life‑saving treatments.
Funding
Funding not disclosed
Founders
Product
Problem
Clinical oncology research and drug development often rely on limited clinical trial data, leading to slow identification of effective therapies and challenges in applying precision medicine to diverse patient populations.
Solution
Inka Health provides an AI-driven analytics platform that processes large-scale, real-world multimodal oncology data—including electronic health records, imaging, genomics, and outcomes—to generate actionable evidence for researchers and pharmaceutical developers. The system applies advanced machine‑learning models and causal inference techniques to uncover treatment effects, patient sub‑group responses, and predictive biomarkers. By delivering validated insights in a reproducible workflow, Inka Health accelerates hypothesis generation, trial design, and regulatory submissions, supporting faster development of life‑saving cancer therapies and more precise treatment selection.
Target Audience
Primary customers are pharmaceutical companies, biotech firms, and academic research groups conducting oncology drug development and precision‑medicine studies.
Features
- Integration of heterogeneous oncology data sources (EHR, imaging, genomics, pathology, claims) into a unified analytical pipeline
- Proprietary AI models for outcome prediction, treatment effect estimation, and patient stratification using causal inference methods
- Automated generation of real‑world evidence reports compliant with regulatory standards (e.g., FDA RWE guidance)
- Interactive dashboards that visualize cohort characteristics, survival curves, and biomarker associations for rapid decision‑making
- Scalable cloud infrastructure enabling analysis of millions of patient records with secure, HIPAA‑compliant data handling
- API access for seamless embedding of analytics into pharmaceutical R&D workflows and clinical trial platforms